Perkins Capital Management »

NeoGenomics shares owned by Perkins Capital Management

Quarter-by-quarter ownership of NeoGenomics (NEO) shares owned by Perkins Capital Management from 13F filings

Historical chart of Perkins Capital Management investment in NeoGenomics

Tip: Access up to 7 years of quarterly data

All positions including NeoGenomics held by Perkins Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NeoGenomics by Perkins Capital Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $925k 373k 2.48

More positions owned by Perkins Capital Management

Eli Lilly & Co. (LLY)
Natera (NTRA)
Microsoft Corporation (MSFT)
IDEXX Laboratories (IDXX)
Axogen (AXGN)
Advanced Micro Devices (AMD)
Elutia Cl A Com (ELUT)
Veracyte (VCYT)
LeMaitre Vascular (LMAT)
Neogenomics Com New (NEO)
Abbott Laboratories (ABT)
Magnite Ord (MGNI)
Ooma (OOMA)
Cantaloupe (CTLP)
Airgain (AIRG)

View all positions for Perkins Capital Management

Top funds holding NeoGenomics

BlackRock
Vanguard Group
Brown Advisory Holdings Incorporated
T. Rowe Price Investment Management
Henderson Group
State Street Corporation
Schroder Investment Management Group
First Light Asset Management
Dimensional Fund Advisors
Macquarie Group
American Century Companies
Geode Capital Management
Goldman Sachs Group
Franklin Resources
Fred Alger Management

View all funds holding NeoGenomics